Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Imprimis Pharmaceuticals Acquires Exclusive License to Patented Ophthalmic Formulation for Dry Eye Disease
Friday, April 07, 2017Imprimis Pharmaceuticals Inc an ophthalmologyfocused pharmaceutical company announced today that it has entered into an licensing agreement for the exclusive worldwide rights to Klarity an innovative and patented ophthalmic topical solution and gel t...
Aurinia Announces Development Plans for Voclosporin in Europe and Japan
Friday, April 07, 2017Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the European Medicines Agency EMA and the Pharmaceutical and Medical Devices Agency PMDA in Japan regarding the development of voclosporin for the treatment of active lupus ne...
Jazz Pharmaceuticals Reaches Settlement with Hikma Pharmaceuticals
Thursday, April 06, 2017Jazz Pharmaceuticals plc announced that certain of its subsidiaries have entered into agreements with Hikma Pharmaceuticals PLC and related entities Hikma resolving patent litigation related to Xyrem sodium oxybate oral solution The litigation which...
Therapix Signs Exclusive License Agreement with Yissum Research Development
Thursday, April 06, 2017Therapix Biosciences Ltd a specialty clinicalstage pharmaceutical company specializing in the development of cannabinoidbased drugs today announced that it has signed a sublicense agreement for Yissum Research Development Company of the Hebrew Univer...
Karyopharm and Medidata Expand Clinical Trial Partnership
Wednesday, April 05, 2017Medidata and clinicalstage pharmaceutical company Karyopharm Therapeutics announced an expanded partnership to bring novel machinelearning technology and targeted riskbased monitoring RBM techniques to clinical oncology trials In addition to renew...
Meiji Seika and Eisai Enter into a Collaboration for the Development and Commercialization of Safinamide
Wednesday, April 05, 2017Eisai Co Ltd and Meiji Seika Pharma Co Ltd announced that they have entered into a license agreement for the commercialization of safinamide development code ME for the treatment of Parkinsons disease in Japan and Asia Safinamide is currently under c...
BioCryst Announces Mundipharma Receives Approval for Mundesine® in Japan
Tuesday, April 04, 2017BioCryst Pharmaceuticals Inc announced that Mundipharma has obtained regulatory approval of Mundesine Forodesine hydrochloride for the treatment of relapsedrefractory PTCL Peripheral TCell Lymphoma by the Ministry of Health Labor and Welfare in Japan...
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
Tuesday, April 04, 2017Ipsen announced that it has completed its acquisition of global oncology assets from Merrimack Pharmaceuticals in Cambridge MA focusing on ONIVYDE irinotecan liposome injection for the treatment of patients with metastatic adenocarcinoma of the pancr...
Puma Biotechnology Launches Expanded Access Program for PB272 (Neratinib)
Monday, April 03, 2017Puma Biotechnology Inc a biopharmaceutical company has initiated an expanded access program EAP in the United States to provide its investigational therapy PB neratinib to patients with HERpositive breast cancer or HERmutated cancers The program will...
Astellas to Acquire Ogeda SA
Monday, April 03, 2017Astellas Pharma Inc and Ogeda SA announced that Astellas and Ogeda shareholders have entered into a definitive agreement under which Astellas has agreed to acquire Ogeda a privately owned drug discovery company Ogeda is a clinicalstage drug discovery...
